Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism clinical trial (NCT07122401). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the possible side effects of MT1013 and cinacalcet?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism clinical trial (NCT07122401). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism clinical trial (NCT07122401). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism clinical trial (NCT07122401). Contact the study team or your healthcare provider for specific answers.

Question 5

How will the trial impact my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism clinical trial (NCT07122401). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism clinical trial (NCT07122401). Contact the study team or your healthcare provider for specific answers.

What this study is about